標(biāo)題: Titlebook: Basic and Clinical Tumor Immunology; Ronald B. Herberman Book 1983 Springer Science+Business Media Dordrecht 1983 Antigen.Staging.cancer t [打印本頁] 作者: 一再 時(shí)間: 2025-3-21 19:41
書目名稱Basic and Clinical Tumor Immunology影響因子(影響力)
書目名稱Basic and Clinical Tumor Immunology影響因子(影響力)學(xué)科排名
書目名稱Basic and Clinical Tumor Immunology網(wǎng)絡(luò)公開度
書目名稱Basic and Clinical Tumor Immunology網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Basic and Clinical Tumor Immunology被引頻次
書目名稱Basic and Clinical Tumor Immunology被引頻次學(xué)科排名
書目名稱Basic and Clinical Tumor Immunology年度引用
書目名稱Basic and Clinical Tumor Immunology年度引用學(xué)科排名
書目名稱Basic and Clinical Tumor Immunology讀者反饋
書目名稱Basic and Clinical Tumor Immunology讀者反饋學(xué)科排名
作者: 使殘廢 時(shí)間: 2025-3-21 21:10
The Immunological Surveillance Hypothesis,an be considered as new insights into the problem. Especially since the possible role of NK cells in IS was proposed some time ago by several tumor immunologists [10–14] as well as by researchers in the NK area [12–14]. What was aptly termed as the ‘rescue’ of IS by NK cells [8] can still be conside作者: CURL 時(shí)間: 2025-3-22 03:18 作者: PLAYS 時(shí)間: 2025-3-22 08:27
Biological Response Modifiers: Current Status and Prospects as Anti-Cancer Agents, the way to a greater understanding of biologics which may exist in exceedingly minute quantities but have tremendous amplifying powers with respect to their effect on host responses. Historically, ‘a(chǎn)ctivity’ has been detected in many biological preparations, but the isolation and purification of th作者: TAP 時(shí)間: 2025-3-22 08:44 作者: 熱情的我 時(shí)間: 2025-3-22 15:53 作者: anthesis 時(shí)間: 2025-3-22 19:06
https://doi.org/10.1007/978-981-19-2900-7an be considered as new insights into the problem. Especially since the possible role of NK cells in IS was proposed some time ago by several tumor immunologists [10–14] as well as by researchers in the NK area [12–14]. What was aptly termed as the ‘rescue’ of IS by NK cells [8] can still be conside作者: 發(fā)炎 時(shí)間: 2025-3-23 00:00
https://doi.org/10.1007/978-981-13-7383-1ing may improve the cure rate but the addition of an alternative modality of treatment such as immunotherapy at the time the total tumour burden is low, possibly immediately after surgery, has long been an attractive approach.作者: monogamy 時(shí)間: 2025-3-23 04:23 作者: Loathe 時(shí)間: 2025-3-23 08:21
https://doi.org/10.1007/978-3-030-80065-9ccessful in human tumor therapy. The difficulties encountered in treating established tumors have served to highlight the need for developing and studying animal models in which the individual parameters for successful immunotherapy can be isolated and examined, the immunologic mechanisms potentiall作者: faddish 時(shí)間: 2025-3-23 10:29 作者: Frenetic 時(shí)間: 2025-3-23 15:20
https://doi.org/10.1007/978-981-19-2900-7ondary tumors, metastases, can develop. Despite remarkable advances in aggressive adjuvant therapy and improvements in general patient care, most deaths of patients with solid cancers are caused by metastases. There are several reasons for the current failure to eradicate metastasis. First, by the t作者: instructive 時(shí)間: 2025-3-23 21:25
Impairment of HDL by Pollutants,onses has grown considerably since the early studies reported some 25 to 30 years ago with 3-methylcholanthrene (MCA)-induced rodent sarcomas [1–3]. It now includes tumors of many types such as carcinomas and sarcomas induced with a broad spectrum of chemical carcinogens [4] many of these belonging 作者: 荒唐 時(shí)間: 2025-3-24 00:06
https://doi.org/10.1007/978-981-13-7383-1with Hodgkins disease, some non-Hodgkins lymphomas, childhood leukaemias and solid tumours, choriocarcinomas and teratocarcinomas. Progress has been much slower with the common solid tumour e.g. those of the lung, breast and gastrointestinal tract. In breast cancer for instance remissions occur in 5作者: 柱廊 時(shí)間: 2025-3-24 03:43
https://doi.org/10.1007/978-981-13-7383-1tumor immunology. It raised the possibility that answers to such basic questions as the existence of tumor-specific antigens in human cancer and whether patients are capable of mounting an immune response to their tumors would finally be answered. Moreover, the application of monoclonal antibodies i作者: deciduous 時(shí)間: 2025-3-24 07:40
Vladimir G. Ivancevic,Tijana T. Ivancevicriented journals and of clinical immunology oriented journals contains at least one article in which some immunologic parameter is defined for a population of cancer patients. Of course, such studies are not confined to malignant disease as an extraordinary volume of literature has accumulated on th作者: ROOF 時(shí)間: 2025-3-24 14:05
Vladimir G. Ivancevic,Tijana T. Ivancevic action involves modulation of the individual’s own biological responses. Although activation of host responses, particularly the host-immune response, has been the goal of therapists for many generations, recent technologic advances have improved our understanding of biological responses making man作者: incisive 時(shí)間: 2025-3-24 18:26 作者: Directed 時(shí)間: 2025-3-24 22:40 作者: constitute 時(shí)間: 2025-3-25 01:22 作者: 晚來的提名 時(shí)間: 2025-3-25 04:58 作者: Rodent 時(shí)間: 2025-3-25 09:29
Basic and Clinical Tumor Immunology978-1-4613-3873-4Series ISSN 0927-3042 Series E-ISSN 2509-8497 作者: languor 時(shí)間: 2025-3-25 12:21
Book 1983extbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often prelimi- nary reports on a very limited number of patients. Certain general journals frequently publish good indepth reviews of cancer topics, and published sympos作者: Rct393 時(shí)間: 2025-3-25 16:45
Specific Antitumor Immunity and its Role in Host Resistance to Tumors,to the classes (polycyclic hydrocarbons, nitrosamines, aromatic amines and aminoazo dyes) which are known, or suspected to be, human carcinogens [5], Rodent tumors induced with DNA- and RNA- containing viruses also express antigens able to induce tumour rejection responses in the host [6, 7].作者: bibliophile 時(shí)間: 2025-3-25 21:13 作者: 灌輸 時(shí)間: 2025-3-26 00:26
https://doi.org/10.1007/978-981-19-2900-7ble obstacle to successful treatment of metastasis is the heterogeneous nature of malignant neoplasms and the rapid emergence of metastases that are resistant to conventional therapeutic regimens [1–3].作者: 演講 時(shí)間: 2025-3-26 04:37
Vladimir G. Ivancevic,Tijana T. Ivancevicerefore, we have tended to concentrate in this review on studies with reasonable numbers of patients, where appropriate statistical analysis was included, and where reproducible methodology was employed. Even so, we have undoubtedly failed to include a large number of completely respectable scientific efforts.作者: Expiration 時(shí)間: 2025-3-26 10:41 作者: diathermy 時(shí)間: 2025-3-26 13:09 作者: 預(yù)示 時(shí)間: 2025-3-26 18:56
Impairment of HDL by Pollutants,to the classes (polycyclic hydrocarbons, nitrosamines, aromatic amines and aminoazo dyes) which are known, or suspected to be, human carcinogens [5], Rodent tumors induced with DNA- and RNA- containing viruses also express antigens able to induce tumour rejection responses in the host [6, 7].作者: Dissonance 時(shí)間: 2025-3-26 23:02
https://doi.org/10.1007/978-981-13-7383-1n the diagnosis and therapy of cancer promises to give the clinician a powerful new approach to the treatment of malignancy. Although none of these goals has yet been achieved it is appropriate at this time to review progress in this area.作者: hemorrhage 時(shí)間: 2025-3-27 02:17
0927-3042 co- logy textbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often prelimi- nary reports on a very limited number of patients. Certain general journals frequently publish good indepth reviews of cancer topics, and publis作者: 金哥占卜者 時(shí)間: 2025-3-27 08:17
The Immunological Surveillance Hypothesis,by . immunologists who in the past only had marginal attachment to tumor immunology [1–7], in one case producing actual experimental work [2, 3] and in another [7] by involvement in natural killer (NK) cell research. Secondly, the possible ‘rescue’ of IS [8] as a viable hypothesis by the recent expl作者: 盡忠 時(shí)間: 2025-3-27 12:03
Role of Macrophages in Host Resistance Against Tumors,ondary tumors, metastases, can develop. Despite remarkable advances in aggressive adjuvant therapy and improvements in general patient care, most deaths of patients with solid cancers are caused by metastases. There are several reasons for the current failure to eradicate metastasis. First, by the t作者: 高興去去 時(shí)間: 2025-3-27 13:38 作者: BIPED 時(shí)間: 2025-3-27 19:29 作者: 單片眼鏡 時(shí)間: 2025-3-27 23:15
Human Tumor Antigens: Detection and Characterization with Monoclonal Antibodies,tumor immunology. It raised the possibility that answers to such basic questions as the existence of tumor-specific antigens in human cancer and whether patients are capable of mounting an immune response to their tumors would finally be answered. Moreover, the application of monoclonal antibodies i作者: 食道 時(shí)間: 2025-3-28 02:43
Immunocompetence in Cancer Patients,riented journals and of clinical immunology oriented journals contains at least one article in which some immunologic parameter is defined for a population of cancer patients. Of course, such studies are not confined to malignant disease as an extraordinary volume of literature has accumulated on th作者: 裂口 時(shí)間: 2025-3-28 08:35 作者: Flinch 時(shí)間: 2025-3-28 14:14 作者: 無法治愈 時(shí)間: 2025-3-28 17:44 作者: 貿(mào)易 時(shí)間: 2025-3-28 21:14
